Adjuvant nivolumab (NIVO) v placebo (PBO) in stage IIB/C melanoma: Update from CheckMate 76K

被引：0

作者：

Kirkwood, J. M. ^{[1
]}

Weber, J. ^{[2
]}

Hoeller, C. ^{[3
]}

Grob, J. ^{[4
]}

Mohr, P. ^{[5
]}

Grabbe, S. ^{[6
]}

Dutriax, C. ^{[2
,7
]}

Chiarion-Sileni, V. ^{[20
]}

Mackiewicz, J. ^{[18
]}

Rutkowski, P. ^{[8
]}

Arenberger, P. ^{[9
,11
]}

Meniawy, T. ^{[19
]}

Dalle, S. ^{[10
,12
]}

Mandala, M. ^{[13
]}

van Akkooi, A. ^{[14
]}

Nassar, A. ^{[15
]}

Campigotto, F.

Long, G. V. ^{[16
]}

Del Vecchio, M. ^{[17
]}

机构：

[1] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[2] NYU Langone Med Ctr, New York, NY USA

[3] Med Univ Wien, Vienna, Austria

[4] Hop La Timone, Marseille, France

[5] Elbe Klinikum Buxtehude, Buxtehude, Germany

[6] Johannes Gutenberg Univ Mainz, Med Ctr, Mainz, Germany

[7] Hop St Andre, Bordeaux, France

[8] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland

[9] Charles Univ Prague, Fac Med 3, Prague, Czech Republic

[10] Hosp Civils Lyon, Lyon, France

[11] Univ Perugia, Lombardia, Italy

[12] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia

[13] Royal Prince Alfred Hosp, Sydney, NSW, Australia

[14] Bristol Myers Squibb, Princeton, NJ USA

[15] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia

[16] Royal North Shore & Mater Hosp, Sydney, NSW, Australia

[17] IRCCS Ist Nazl Tumori, Milan, Italy

[18] Poznan Univ Med Sci, Inst Oncol, Poznan, Poland

[19] Sir Charles Gairdner Hosp, Perth, WA, Australia

[20] Ist Oncol Veneto IOV IRCCS, Padua, Italy

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

279

引用

页码：S48 / S48

页数：1